SCTC
GILD icon

Sanibel Captiva Trust Company’s Gilead Sciences GILD Stock Holding History

Sanibel Captiva Trust Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Buy
21,308
+884
+4% +$116K 0.07% 173
2026
Q1 		$2.85M Buy
20,424
+2,380
+13% +$333K 0.08% 162
2025
Q4 		$2.21M Buy
18,044
+432
+2% +$52.5K 0.06% 175
2025
Q3 		$1.95M Buy
17,612
+137
+0.8% +$15.6K 0.06% 180
2025
Q2 		$1.94M Buy
17,475
+706
+4% +$75.1K 0.06% 175
2025
Q1 		$1.88M Sell
16,769
-1,053
-6% -$109K 0.06% 175
2024
Q4 		$1.65M Sell
17,822
-303
-2% -$27.3K 0.05% 179
2024
Q3 		$1.52M Sell
18,125
-1,234
-6% -$94.2K 0.05% 187
2024
Q2 		$1.33M Sell
19,359
-251
-1% -$16.8K 0.05% 187
2024
Q1 		$1.44M Sell
19,610
-62
-0.3% -$4.77K 0.05% 176
2023
Q4 		$1.59M Buy
+19,672
New +$1.53M 0.06% 161

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanibel Captiva Trust Company's GILD Position: Q2 2026 in Review

Sanibel Captiva Trust Company increased its Gilead Sciences (GILD) stake by 4.3% in Q2 2026, buying an estimated $116K and bringing the position to 21,308 shares worth $2.69M. The position accounts for 0.07% of the portfolio, ranked #173.

Sanibel Captiva Trust Company first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.85M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sanibel Captiva Trust Company held 21,308 shares of Gilead Sciences worth $2.69M as of Q2 2026.
  • Sanibel Captiva Trust Company bought 884 Gilead Sciences shares in Q2 2026, an estimated $116K.
  • Gilead Sciences made up 0.07% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #173 holding.
  • Sanibel Captiva Trust Company first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Sanibel Captiva Trust Company's Gilead Sciences position peaked at $2.85M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.